首页> 外国专利> GELATIN METHACRYLOYL-BASED MICRONEEDLE PATCHES FOR DELIVERY OF WATER-INSOLUBLE DRUGS

GELATIN METHACRYLOYL-BASED MICRONEEDLE PATCHES FOR DELIVERY OF WATER-INSOLUBLE DRUGS

机译:明胶基甲基丙烯酰基微针贴剂,用于递送水不溶性药物

摘要

A patch incorporates biodegradable microneedles (MNs) that are fabricated from naturally derived polymer conjugates of gelatin methacryloyl and β-cyclodextrin (GelMA-β-CD). When curcumin, an unstable and water-insoluble anticancer therapeutic agent, is loaded as an example, its stability and solubility are improved due to the formation of inclusion complex. The polymer-drug complex GelMA- β-CD/CUR can be formulated into MN arrays with sufficient mechanical strength for skin penetration and tunable drug release profile. Anticancer efficacy of released curcumin is observed in three-dimensional (3D) B16F10 melanoma models. The GelMA-β-CD/CUR MN exhibits relatively higher therapeutic efficacy through more localized and deeper penetrated manner compared with a control non-transdermal patch. In vivo studies verify biocompatibility and degradability of the GelMA-β-CD MN-based patch. Other water-insoluble therapeutic agents may be loaded into the patch.
机译:贴剂包含可生物降解的微针(MN),其由明胶甲基丙烯酰基和β-环糊精(Gelma-β-CD)的天然衍生的聚合物缀合物制成。 当姜黄素,不稳定和水不溶性抗癌的治疗剂被装载时,其稳定性和溶解度由于包合物的形成而得到改善。 聚合物 - 药物复合胶凝胶-β-CD / Cd可以配制成具有足够机械强度的Mn阵列,用于皮肤穿透和可调谐药物释放曲线。 在三维(3D)B16F10黑色素瘤模型中观察到释放姜黄素的抗癌疗效。 与对照非透皮贴剂相比,GELMA-β-CD / CD / CD MN通过更局部和更深的穿透方式表现出相对较高的治疗效果。 体内研究验证了凝胶-β-CD Mn的贴剂的生物相容性和可降解性。 其他水不溶性治疗剂可以装入贴剂中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号